4//SEC Filing
WG Biotech ApS 4
Accession 0001104659-23-125055
CIK 0001722964other
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 5:25 PM ET
Size
9.7 KB
Accession
0001104659-23-125055
Insider Transaction Report
Form 4
WG Biotech ApS
Director10% Owner
Transactions
- Purchase
Common stock
2023-12-08$6.99/sh+18,503$129,379→ 4,449,915 total - Purchase
Common Stock
2023-12-07$6.50/sh+6,183$40,190→ 4,431,412 total - Purchase
Common stock
2023-12-11$7.01/sh+102,863$720,843→ 4,552,778 total
Footnotes (3)
- [F1]This transaction was executed in multiple trades each at price of $6.50. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $6.90 to $7.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $6.86 to $7.15. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Y-mAbs Therapeutics, Inc.
CIK 0001722964
Entity typeother
IncorporatedDenmark
Related Parties
1- filerCIK 0001753193
Filing Metadata
- Form type
- 4
- Filed
- Dec 10, 7:00 PM ET
- Accepted
- Dec 11, 5:25 PM ET
- Size
- 9.7 KB